Zhang Li-na, Zheng Jia-jia, Zhang Li, Gong Xia, Huang Hai, Wang Chang-dong, Wang Bin, Wu Meng-jiao, Li Xiao-hui, Sun Wen-juan, Liu Ying-ju, Wan Jing-yuan
Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Medical University, Yixueyuan Road 1, Yuzhong District, Chongqing 400016, China.
Exp Toxicol Pathol. 2011 Sep;63(6):519-25. doi: 10.1016/j.etp.2010.04.002. Epub 2010 May 14.
Asiaticoside (AS), a major triterpenoid saponin component isolated from Centella asiatica, has been described to exhibit antioxidant and anti-inflammatory activities. The present study aimed to determine the protective effects and the underlying mechanisms of AS on septic lung injury induced by cecal ligation and puncture (CLP). Mice were pretreated with the AS (45 mg/kg) or AS as well as GW9662 at 1h before CLP, the survival, lung injury, inflammatory mediators and signaling molecules, and Peroxisome proliferator-activated receptor-γ (PPAR-γ) were determined 24 h after CLP. The results showed that AS significantly decreased CLP-induced the mortality, lung pathological damage, the infiltration of mononuclear, polymorphonuclear (PMN) leucocytes and total proteins. Moreover, AS inhibited CLP-induced the activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-κB (NF-κB), the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) protein in lung tissues, and the production of serum tumor necrosis factor (TNF-α) and interleukin-6 (IL-6). Interestingly, the expression of PPAR-γ protein in lung tissue was up-regulated by AS. Furthermore, GW9662 (the inhibitor of PPAR-γ) significantly reversed these beneficial effects of AS in septic mice. These findings suggest that AS could effectively protect from septic lung injury induced by CLP and the underlying mechanisms might be related to up-regulation of PPAR-γ expression to some extent, which inhibits MAPKs and NF-κB pathway.
积雪草苷(AS)是从积雪草中分离出的一种主要的三萜皂苷成分,已被描述具有抗氧化和抗炎活性。本研究旨在确定AS对盲肠结扎和穿刺(CLP)诱导的脓毒症肺损伤的保护作用及其潜在机制。在CLP前1小时,用AS(45mg/kg)或AS以及GW9662对小鼠进行预处理,在CLP后24小时测定生存率、肺损伤、炎症介质和信号分子以及过氧化物酶体增殖物激活受体-γ(PPAR-γ)。结果表明,AS显著降低了CLP诱导的死亡率、肺病理损伤、单核细胞、多形核(PMN)白细胞浸润和总蛋白。此外,AS抑制了CLP诱导的丝裂原活化蛋白激酶(MAPKs)和核因子-κB(NF-κB)的激活、肺组织中环氧合酶-2(COX-2)和诱导型一氧化氮合酶(iNOS)蛋白的表达以及血清肿瘤坏死因子(TNF-α)和白细胞介素-6(IL-6)的产生。有趣的是,AS上调了肺组织中PPAR-γ蛋白的表达。此外,GW9662(PPAR-γ抑制剂)显著逆转了AS对脓毒症小鼠的这些有益作用。这些发现表明,AS可以有效保护免受CLP诱导的脓毒症肺损伤,其潜在机制可能在一定程度上与PPAR-γ表达上调有关,从而抑制MAPKs和NF-κB途径。